Tina Woods is a mission-driven social entrepreneur and system architect bringing diverse stakeholders together in shared endeavours to improve health, working at the cross section of science, technology, investment and policy/government. 

She is Founder and CEO of Collider Health and works with private, public and third sectors. 

She is Founder and CEO of Business for Health, a business-led social venture to measure and incentivise business contribution health, linking health with economic growth in three key areas as part of a system change approach towards a prevention-based model of health: 1) workforce health; 2) consumer health and 3) community health.

She is Founder and CEO of Collider Health and Business for Health and as a Steering Committee member of the Human Exposome Project a leading voice in the emerging field of the human exposome — understanding how environment, lifestyle and connection shape long-term health and resilience.

She brings together academia, business and government to drive system change from ‘sickcare’ to prevention — while also living her message as founder of Longevity Rave, leader of the JoyScore Experiment  and DJ Tina Technotic.

She is the Healthy Longevity Champion for the National Innovation Centre for Ageing, co-leading the Quantum Healthy Longevity Innovation Mission and City of Longevity programme.

Tina is the co-founder of Longevity Rave (and DJs as Tina Technotic), a collective of entrepreneurs, scientists, DJs and artists that organise raves around the world using the power of music, joy and connection to bring the generations together to dance and celebrate life and humanity.

She is former Executive Director of the International Institute of Longevity, combining her interest in taking the latest science and technology of longevity into the 'next frontier' of the Human Exposome to understand what drives human healthspan, resilience and flourishing. 

Tina was director of the  All Party Parliamentary Group for Longevity secretariat (2016-2023)

Tina sits on various advisory groups, including the Steering Committee for the Exposome Moonshot,  XPRIZE  Global Visioneering Brain Trust, and Global Commission on Healthy Indoor Air. Formerly, she was on the Strategic Advisory Board for the BBSRC Bioscience for an Integrated Understanding of Health,  BSI Standards Group for AI in health and care and trustee for the British Society for Research on Ageing. She was involved in the early days of setting up the NHSX AI lab and ethical application of AI in the UK healthcare system, and on the Ada Lovelace Institute advisory board to address inequalities in data-driven healthcare systems.

She studied genetics at Cornell University in the USA and also has an MBA from Bayes Business School in London.

Tina’s book, ‘Live Longer with AI: How artificial intelligence is helping us extend our healthspan and live better too' was published  in October 2020. 

She has been involved as an author in a number of scientific papers including:

  • Kern, C., Woods, T., & Siew, K. (2026). Tackling aging and chronic disease: How space exploration and the ‘chameleon effect’ of pharmaceuticals can lead the way. Experimental Physiology, 1–9. https://doi.org/10.1113/EP092652

  • Woods T, Palmarini N, Corner L, Bischof EY, Furman D, Kansara T, Kern C, Sille F, Olsen A. The Human Exposome: Whole-System Health Underpinning Advances in Human Healthspan, Resilience, and Flourishing; Springer Nature, Frontiers of Longevity Science, Vol. 1. The Biology of Life Extension. Oct 2026

  • Mark Haden, Birgitta Woods, Tina Woods & Kenneth W. Tupper (2026). Psychedelics and longevity: implications for lifespan, healthspan and functional aging, Longevity, 7:1, 2696224, DOI: 10.1080/30653495.2026.2696224

  • Woods T,  Palmarini N, Corner L., Furman D, Miller G, Shiels P, Argentieri A. (2026). New frontier of longevity- through the framework of the ‘exposome’, Stambler I (ed) Healthy Longevity: Policies and Practices. Book series Healthy Ageing and Longevity. Springer Nature, Cham, 2026 (in press) https://www.springer.com/series/13277

  • Kern CC, Jenkins A, Reddy DN, et al. Beyond GLP-1s: The blueprint for systemic therapeutics that will reshape aging and medicine. Br J Clin Pharmacol. 2025; 91(12): 3309-3314. doi:10.1002/bcp.70312

  • Shiels P, Neytchev O, Borland G, Germushkina P, Johnson R, Stenvinkel P, Woods T. Ignoring the planet: A critical blind spot for research on ageing. J Intern Med. 2025 Dec;298(6):578-590. doi: 10.1111/joim.70032. Epub 2025 Oct 22. PMID: 41122814; PMCID: PMC12617485.

  • Bensz, J., Verdin, E., Karow, D. S., Maier, A. B., Bischof, E., Woods, T., … Kapp, W. (2026). Advancing longevity clinics – an international roundtable. Longevity6(1). https://doi.org/10.1080/30653495.2025.2595857

  • Albertyn, C. P., Surodina, S., Świeboda, P., Tan, B., Woods, T., Corner, L., … Siow, R. C. (2026). Proposing a person-centred health data ecosystem framework to optimise digital innovation and artificial intelligence for dementia prevention and cognitive longevity. Longevity6(1). https://doi.org/10.1080/30653495.2025.2570721

  • Lyu YX, Fu Q, Wilczok D, Ying K, King A, Antebi A, Vojta A, Stolzing A, Moskalev A, Georgievskaya A, Maier AB, Olsen A, Groth A, Simon AK, Brunet A, Jamil A, Kulaga A, Bhatti A, Yaden B, Pedersen BK, Schumacher B, Djordjevic B, Kennedy B, Chen C, Huang CY, Correll CU, Murphy CT, Ewald CY, Chen D, Valenzano DR, Sołdacki D, Erritzoe D, Meyer D, Sinclair DA, Chini EN, Teeling EC, Morgen E, Verdin E, Vernet E, Pinilla E, Fang EF, Bischof E, Mercken EM, Finger F, Kuipers F, Pun FW, Gyülveszi G, Civiletto G, Zmudze G, Blander G, Pincus HA, McClure J, Kirkland JL, Peyer J, Justice JN, Vijg J, Gruhn JR, McLaughlin J, Mannick J, Passos J, Baur JA, Betts-LaCroix J, Sedivy JM, Speakman JR, Shlain J, von Maltzahn J, Andreasson KI, Moody K, Palikaras K, Fortney K, Niedernhofer LJ, Rasmussen LJ, Veenhoff LM, Melton L, Ferrucci L, Quarta M, Koval M, Marinova M, Hamalainen M, Unfried M, Ringel MS, Filipovic M, Topors M, Mitin N, Roy N, Pintar N, Barzilai N, Binetti P, Singh P, Kohlhaas P, Robbins PD, Rubin P, Fedichev PO, Kamya P, Muñoz-Canoves P, de Cabo R, Faragher RGA, Konrad R, Ripa R, Mansukhani R, Büttner S, Wickström SA, Brunemeier S, Jakimov S, Luo S, Rosenzweig-Lipson S, Tsai SY, Dimmeler S, Rando TA, Peterson TR, Woods T, Wyss-Coray T, Finkel T, Strauss T, Gladyshev VN, Longo VD, Dwaraka VB, Gorbunova V, Acosta-Rodríguez VA, Sorrentino V, Sebastiano V, Li W, Suh Y, Zhavoronkov A, Scheibye-Knudsen M, Bakula D. Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity. Aging (Albany NY). 2024 Oct 16;16(20):12955-12976. doi: 10.18632/aging.206135. Epub 2024 Oct 16. PMID: 39418098; PMCID: PMC11552646.

  • Jacques E, Herzog C, Ying K, et al. Invigorating discovery and clinical translation of aging biomarkers. Nat Aging. 2025 Apr;5(4):539-543. doi: 10.1038/s43587-025-00838-w PMID: 40164770

  • Woods T, Palmarini N, Corner L, Barzilai N, Maier AB, Sagner M, Bensz J, Strygin A, Yadala N, Kern C, Ward P, Ferrucci L, Bischof EY, Barker R, Shiels PG, Guiot G, Monti J, Justice J, Kennedy BK, Furman D. Cities, communities and clinics can be testbeds for human exposome and aging research. Nat Med. 2025 Apr;31(4):1066-1068. doi: 10.1038/s41591-025-03519-8 PMID: 40075229

  • Jacques, E., Herzog, C., Ying, K. et al. Invigorating discovery and clinical translation of aging biomarkers. Nat Aging 5, 539–543 (2025). https://doi.org/10.1038/s43587-025-00838-w

  • Woods T, Palmarini N, Corner L, Siow R. Quantum healthy longevity from cells to cities. Front Aging. 2024 Aug 13;5:1416447. doi: 10.3389/fragi.2024.1416447 PMID: 39193426; PMCID: PMC11347422.

  • Lyu YX, Fu Q, Wilczok D, et al. Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity. Aging (Albany NY). 2024 Oct 16;16(20):12955-12976. doi: 10.18632/aging.206135 Epub 2024 Oct 16. PMID: 39418098; PMCID: PMC11552646.

  • Woods T, Palmarini N, Corner L, Barzilai N, Bethell LJ, Cox LS, Eyre H, Ferrucci L, Fried L, Furman D, Kennedy B, Roddam A, Scott A, Siow RC. Quantum Healthy Longevity for healthy people, planet, and growth. Lancet Healthy Longev. 2022 Dec;3(12):e811-e813. doi: 10.1016/S2666-7568(22)00267-7 Epub 2022 Nov 13. PMID: 36384162.

  • Green D, Filkin G, Woods T; All-Party Parliamentary Group for Longevity. Our unhealthy nation. Lancet Healthy Longev. 2021 Jan;2(1):e8-e9. doi: 10.1016/S2666-7568(20)30062-3. Epub 2020 Dec 8. Erratum in: Lancet Healthy Longev. 2022 Oct;3(10):e652. doi: 10.1016/S2666-7568(22)00226-4 PMID: 36098161; PMCID: PMC9529172.

  • Green D, O'Shaughnessy J, Starks G, Sloggett R, Buchan I, Woods T; All-Party Parliamentary Group for Longevity. Open Life Data to support healthy longevity for all. Lancet Healthy Longev. 2021 May;2(5):e238-e239. doi: 10.1016/S2666-7568(21)00081-7 Epub 2021 Apr 8. PMID: 36098125.